Clinical Trials in Houston

Showing 10981-11000 of 17,885 trials

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

NCT01067469

The goal of this clinical research study is to learn if the combination of bevacizumab and lomustine can help to control glioblastoma. The safety of this combination will also be studied.

Brain CancerGlioblastoma

M.D. Anderson Cancer Center83 participantsStarted Jan 2010

Houston, Texas, United States

TERMINATEDPhase 1/2< 1 mile

Phase II Study of TAK228 in Relapsed Lymphoma

NCT02727777

The goal of this clinical research study is to learn if TAK-228 can help to control relapsed lymphoma. The safety of this drug will also be studied.

Lymphoma

M.D. Anderson Cancer Center4 participantsStarted Mar 2017

Houston, Texas, United States

TERMINATEDNA< 1 mile

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

NCT00981578

A study to evaluate the safety and initial effectiveness of the ExAblate 2100 Conformal Bone System in the treatment of pain resulting from metastatic bone tumors.

Bone Metastases

InSightec37 participantsStarted Sep 2009

Duarte, California, United States • San Francisco, California, United States • Stanford, California, United States +2 more locations

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Phase II Study of TAK228 in Relapsed Lymphoma

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Find Trials by Condition in Houston

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )

Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis

Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain

Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers

Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.

Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD

VITROS Immunodiagnostic Products NT-proBNP II

Meditation in Veterans With PTSD and Mild TBI

Pilot RCT of an Obesity Intervention for Primary Care Pediatrics: Helping HAND

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis

Genetic Analysis of Hereditary Prostate Cancer

Novel Endoluminal Clinical TreAtment of Reflux

Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event